Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenotype and function of proinflammatory dendritic cells during etanercept therapy for plaque psoriasis
2007-007170-30Phase 4Active
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in plaque psoriasis, sponsored by Technische Universität Dresden. Primary endpoint: PASI75 response at week 24. Started Jan 2008; status: active.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2007-007170-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007170-30.